CLINIMAX is a British company specialising in the research, development and manufacture of innovative infection control products for use in the healthcare environment.
Bio-security is of ever increasing importance in today’s world of new and potentially fatal pathogens. Micro-organisms are continually evolving, making new disease strains a constant threat in all areas of healthcare. The need for an effective environmental disinfection policy has never been greater. The company’s Difficil-S products have been independently tested by the Hospital Infection Research Laboratory in Birmingham, recognised as being one of the most highly regarded test laboratories in the world, while an independent study by Speight et al (2011), also showed the product to be highly effective against Clostridium difficile spores (NCTC 11209).
